US › Healthcare

Accuray Incorporated (ARAY)

US · Healthcare · Medical Devices

$0.11-11.22%

Last close · 2026-11-06

Latest quarter · ended 2026-09-30

Revenue

$86.5M

Revenue YoY

-7.9%

Net profit

$10.1M

EPS

$0.07

EPS estimate

$-0.07

Net margin

11.7%

EPS came in at 0.07 against a street estimate of -0.07 — a beat of 200.0%.

Key statistics

Market cap

$17.8M

Forward P/E

94.3

P/B

0.41

Book value

$0.35

EPS (TTM)

$-0.40

52-week high

$1.27

52-week low

$0.11

50-day MA

$0.22

200-day MA

$0.36

Beta

1.38

Analyst view

with an average price target of $0.35.

Shareholding

Insiders

4.62%

Institutions

64.44%

Largest institutional holders

Fund	Stake
TCW Group Inc	15.86%
Neuberger Berman Group LLC	5.09%
Armistice Capital, LLC	4.80%
Weber Capital Management LLC	4.05%
Vanguard Capital Management, LLC	3.72%
BlackRock Inc	2.73%
AQR Capital Management LLC	2.28%
Jane Street Group LLC	1.79%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Accuray Incorporated — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.